Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Verrica Pharmaceuticals Q1 Adj. EPS $(0.08) Beats $(0.10) Estimate, Sales $3.44M Beat $2.51M Estimate

Author: Benzinga Newsdesk | May 13, 2025 03:13pm
Verrica Pharmaceuticals (NASDAQ:VRCA) reported quarterly losses of $(0.08) per share which beat the analyst consensus estimate of $(0.10) by 20 percent. This is a 78.95 percent increase over losses of $(0.38) per share from the same period last year. The company reported quarterly sales of $3.44 million which beat the analyst consensus estimate of $2.51 million by 36.94 percent. This is a 10.12 percent decrease over sales of $3.83 million the same period last year.

Posted In: VRCA


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist